Improving Standard of Care Through Variety

Alexander Bastian

Video Categories: ASH 2014

Alexander Bastian says the most important thing to come out of ASH that will improve standard of care is the variety of treatments coming available, including a new drug from Amgen for treating ALL.

Related Videos

October 1, 2018

How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely Performed

Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer [ Read More ]

January 20, 2016

Do Therapeutic Agents Affect Healthy Stem Cells?

Dr Wainberg and Dr Gerson ponder and provide opinions on whether these investigational therapies also target healthy cells.